Can PDUFA V solve biopharma's R&D productivity crisis?
04:20 EDT 21 Jun 2012 | SCRIP
There is a certain irony that the one issue that is actually garnering broad bipartisan support on Capitol Hill this year – user fees – is something that involves the US FDA, a "regulatory agency that, frankly, has not been.....
Original Article: Can PDUFA V solve biopharma's R&D productivity crisis?
More From BioPortfolio on "Can PDUFA V solve biopharma's R&D productivity crisis?"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
